Early Phase 1 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 70 years old
- You are willing to sign a consent form and follow all study requirements for the full duration of the trial
- You own a smartphone (iPhone or Android)
- You currently eat across a window of 12 hours or more per day, and are able to log your eating using the myCircadianClock app
- You have been diagnosed with moderate to severe obstructive sleep apnea (a sleep condition where breathing repeatedly stops during sleep) that is not currently being treated
- If you take certain heart or cholesterol medications (such as statins, other cholesterol-lowering drugs, or blood pressure medications), you agree not to change your dose during the study
- You agree to follow the lifestyle guidelines set out by the study for its full duration
Who may not be able to join:
- You have type 1 or type 2 diabetes and take insulin or sulfonylurea medications, or you have ever had a low blood sugar episode without being aware of it
- You have sleep apnea and also experience significant daytime sleepiness, either scoring 15 or higher on a standard sleepiness questionnaire, or having been in a car accident due to excessive sleepiness in the past year
- Your BMI (a measure of body weight relative to height) is over 40
- You have high blood pressure that is not well controlled
- You currently smoke or use illicit drugs
- You are pregnant or breastfeeding
- You are currently taking part in a weight-loss or weight-management program
- You are currently following a special or medically prescribed diet (for example, for Celiac disease)
- You are currently taking any medication intended for weight loss or known to reduce appetite
- You have a history of an eating disorder
- You have previously had surgery for weight management
- You have chronic kidney disease
- You are currently being treated for an active inflammatory condition, rheumatologic (joint/immune) disease, or cancer
- You have heart or artery disease that has not been treated with a procedure to restore blood flow
- You have liver cirrhosis or significantly abnormal liver function
- You have a thyroid condition that required a change in your thyroid medication dose within the past 3 months (note: having hypothyroidism on a stable, unchanged dose does not exclude you — confirm with trial site)
- You work shift work with variable hours, including occasional night shifts
- You are planning to travel outside the United States during the study
- You have a history of HIV/AIDS
- You have a psychiatric condition that is not well controlled
- A study doctor has another safety concern about your participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of TRE vs SE on change in mean daily glucose level; Effect of TRE vs SE on change in serum LDL cholesterol; Effect of TRE vs SE on change in OSA severity; Effect of TRE on quality of life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.